TOKYO - A method developed by a Japanese team using three questions allows easy screening of Alzheimer's disease and mild cognitive impairment, it said Thursday, with a rising number of patients calling for early diagnosis and treatment.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
